October 09, 2018 – Breakthrough innovation specialist Cambridge Consultants today announced a watershed moment for intravascular surgery, with the demonstration of a single-use, high-definition miniature camera. Called ‘Leap’, the technology allows a digital view inside veins and arteries for the first time.

Designing disruptive technology to revolutionise diagnosis & treatment

Leap builds on the latest generation of Omnivision's sub-millimetre cameras, enabling surgeons to visualize parts of the anatomy that are currently inaccessible with today’s imaging techniques. With potential for even smaller cameras on the horizon, this highly miniaturized ‘chip-on-tip’ architecture features a 400 x 400 pixel image (0.16 megapixels) as a standard capability, an order of magnitude improvement over standard fiber-optic angioscopes. Chip-on-tip refers to the location of the imaging sensor at the distal end of the endoscope, in contrast to traditional fiber bundles which transmit light to large, external processing towers.

In the future, Leap technology could be combined with Cambridge Consultants’ ‘super-resolution’ image processing to increase the resolution further to 1600 x 1600 pixels (2.6 megapixels). This state-of-the-art, proprietary technique harnesses deep learning to enhance low resolution images without the blurring associated with traditional upscaling and will ultimately provide visualization for the most challenging cardiovascular surgery.

Despite the ability to provide unique predictive information, current surgical endoscopes are not widely used in angioscopy due to poor flexibility, a limited field of view and low resolution. At 1.35 mm in diameter, the Leap early prototype is small and flexible enough for use in a procedure such as intracoronary angioscopy. Leap increases the information available to surgeons with new functionality, such as enabling tissue classification or direct imaging of non-standard vascular occlusions. Moving beyond the traditional endoscope, inspection with a Leap device could be paired with today’s leading technologies, such as IVUS (Intravascular Ultrasound) and OCT (Optical Coherence Tomography), enabling enhanced diagnostic techniques during surgery.

Existing endoscopes also carry an elevated risk of infection and device damage due to inadequate sterilization between procedures. Leap overcomes a number of these barriers, being an inexpensive, single-use endoscope and can be operated from a standard computer, not relying on the availability of large and expensive operating room infrastructure. Due to the falling costs of chip-on-tip technology, the expense associated with traditional endoscope systems are set to significantly reduce. This is achieved with the introduction of an economical, reposable device, removing the need for sterilization and maintenance.

“We have combined our intravascular device experience with our knowledge of micro‑optics, systems engineering and AI, in conjunction with external manufacturing partners. The result is an economically viable, disposable camera system that is small enough to fit into the working channel of a typical vascular catheter,” said Simon Karger, Head of Surgical and Interventional Products at Cambridge Consultants. “For the first time, Leap offers practical, direct visualization in the procedure room and a platform for integration of new configurations, sensor types and imaging modalities (such as spectroscopy). This can enable a new level of advanced imaging in intravascular procedures and an unparalleled surgical experience” he added.

Leap will be showcased at Asia Pacific MedTech Forum 2018 in Singapore, October 9th to 10th, Stand 25.

Notes to editors

Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology-critical issues for clients worldwide. For more than 50 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of more than 800 staff, including engineers, scientists, mathematicians and designers, in offices in Cambridge (UK), Boston (USA) and Singapore, Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, digital health, energy and wireless communications. For more information, visit: www.cambridgeconsultants.com

Cambridge Consultants is part of Altran, the undisputed global leader in Engineering and R&D services (ER&D), following its acquisition of Aricent. The company offers clients an unmatched value proposition to address their transformation and innovation needs. Altran works alongside its clients, from initial concept through industrialization, to invent the products and services of tomorrow.

For over 30 years, the company has provided expertise in aerospace, automotive, defense, energy, finance, life sciences, railway and telecommunications. The Aricent acquisition extends this leadership to semiconductors, digital experience and design innovation. Combined, Altran and Aricent generated revenues of €2.9 billion in 2017, with some 45,000 employees in more than 30 countries.

PRESS CONTACTS

Cambridge Consultants

Richard
Leyland
Public Relations Manager
Cambridge Consultants

European agency

Mark
Walsh